Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fujian Wu

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Circulation Research|February 14, 2022
Targeting CaMKII-δ9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial InflammationYuan Yao, Fan Li, Mao Zhang, et al.
Nature Cell Biology|September 5, 2019
CaMKII-δ9 promotes cardiomyopathy through disrupting UBE2T-dependent DNA repairMao Zhang, Hua Gao, Dairu Liu, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
NKX2-5 congenital heart disease mutations show diverse loss and gain of epigenomic, biochemical and chromatin search functions underpinning pathogenicityAlexander O Ward, Nicole Schonrock, Alex J McCann, et al.
Circulation|March 23, 2022
Novel CaMKII-δ Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor GrowthJunxia Zhang, Ruqi Liang, Kai Wang, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Circulation Research|February 14, 2022
Targeting CaMKII-δ9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial InflammationYuan Yao, Fan Li, Mao Zhang, et al.
Nature Cell Biology|September 5, 2019
CaMKII-δ9 promotes cardiomyopathy through disrupting UBE2T-dependent DNA repairMao Zhang, Hua Gao, Dairu Liu, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
NKX2-5 congenital heart disease mutations show diverse loss and gain of epigenomic, biochemical and chromatin search functions underpinning pathogenicityAlexander O Ward, Nicole Schonrock, Alex J McCann, et al.
Circulation|March 23, 2022
Novel CaMKII-δ Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor GrowthJunxia Zhang, Ruqi Liang, Kai Wang, et al.
Pageof 4